|
|
|
|
Special Packaging Delivers Inhaled Insulin
Globally, 194 million people suffer from diabetes and this number is rising rapidly. For these patients, a regular regimen of pills or injectable insulin is necessary to control blood-glucose levels. Bringing Exubera, the world's first inhaled insulin, to market requires extensive collaboration by
Pfizer, Nektar Therapeutics, West Pharmaceutical Services Tech
Group, and Bespak.
|
| |
More>>
|
|
|
|
|
|
|
|
|
|
|
|
|
|